Sangamo Therapeutics, Inc. · NASDAQ:SGMO

Wasatch Advisors LP reported a 6.60% stake in Sangamo Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Jan 7, 2025

Wasatch Advisors LP reported a 6.60% stake in Sangamo Therapeutics, Inc., 13,993,410 shares, as a passive investor on Dec 31, 2024. Filed Jan 7, 2025 (Schedule 13G/A).

Stake
6.60%
Shares
13,993,410
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
WASATCH ADVISORS LP6.60%13,993,410

Source

View original at SEC

Related